Medicines A–Z
M
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Methotrexate injections | Supported with an ESCA. Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally. |
|
|
Methotrexate tablets (2.5mg) | ESCA. Methotrexate tablets - use 2.5mg strength only. Methotrexate injection - Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally. |
|
|
Methotrexate | ESCA |
|
 |
Methotrexate | Specialist use only in neurological conditions |
|
|
Methoxy polyethelene glycol-epoetin beta (Mircera) | NHSE commissioned renal dialysis. CCG commissioned for use in cancer - NICE TA323. |
|
|
Methoxyflurane (Penthrox®) | For severe pain of traumatic origin and facilitation of management of significant fractures and dislocations |
|
|
Methoxypsoralen-5 20mg tablets | ||
|
Methyl aminolevulinate cream (Metvix®) | ||
|
Methyldopa tablets | ||
|
Methylphenidate M/R tablets | Specialist initiation only, ESCA |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
